Aptose Biosciences Inc. (LTI0)
Market Closed
16 Jun, 20:00
XFRA 
€
1. 28
-0.04
-3.0303%
€
3.62M Market Cap
- P/E Ratio
- Div Yield
4 Volume
- Eps
€ 1.32
Previous Close Want to track LTI0 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Aptose Biosciences Inc. (LTI0) Statistics
Valuation metrics
Market Cap 3.62M
Enterprise value 30.59M
Trailing P/E (ttm) 2.42
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) -
Enterprise Value/Revenue -
Enterprise Value/EBITDA -1.35
Overview
Shares outstanding 2.55M
Float 1.86M
Shares short -
% Held by insiders 0.27%
% Held by institutions 0.04%
Average volume (10 days) 2
Average volume (90 days) 2
Price summary
52-Week low 0.66
52-Week high 1.52
Beta -
50-Day moving average 1.4
200-Day moving average 1.24
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:30
Last split Date 26 Feb 2025
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.82%
Return on equity 0.94%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -22.74M
Net income to common (ttm) -23.71M
Diluted EPS (ttm) -8.89
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 877.72K
Total cash per share (mrq) 0.4
Total debt (mrq) 28.35M
Total Debt/Equity (mrq) -1.04
Current ratio (mrq) 0.55%
Book value per share (mrq) -9.05
Cash Flow
Cash flow statement -21.54M
Levered free cash flow (LFCF) -12.36M
